From the reviews of the second edition:
"It is intended as a review and reference resource on topics of interest to scientists working in the opioid receptor field. ... would be most appropriate for midlevel graduate students and higher level researchers ... . The book offers a detailed overview and review of 14 different aspects of opioid receptor science ... . an excellent source for a graduate level course on opioid pharmacology, or would serve well as a current reference point on timely issues in this field of research." (Kenneth E. McCarson, Doody's Review Service, June, 2011)
"The major goal of this second edition of The Opiate Receptors is to provide insight into the molecular and classical pharmacology of opiates and opioid peptides and to translate this into pharmacological actions. Gavril Pasternak ... does a masterful job of bringing all of this together. ... This book will be a valuable resource for scientists working in the opiate field and for clinicians who are interested in the pharmacological actions of these agents." (Dwight Moulin, Canadian Journal of Neurological Sciences, March, 2012)
"It is intended as a review and reference resource on topics of interest to scientists working in the opioid receptor field. ... would be most appropriate for midlevel graduate students and higher level researchers ... . The book offers a detailed overview and review of 14 different aspects of opioid receptor science ... . an excellent source for a graduate level course on opioid pharmacology, or would serve well as a current reference point on timely issues in this field of research." (Kenneth E. McCarson, Doody's Review Service, June, 2011)
"The major goal of this second edition of The Opiate Receptors is to provide insight into the molecular and classical pharmacology of opiates and opioid peptides and to translate this into pharmacological actions. Gavril Pasternak ... does a masterful job of bringing all of this together. ... This book will be a valuable resource for scientists working in the opiate field and for clinicians who are interested in the pharmacological actions of these agents." (Dwight Moulin, Canadian Journal of Neurological Sciences, March, 2012)